Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Longitudinal Observational Study of the Natural History and Management of Patients With Hepatocellular Carcinoma

NCT02954094 is registered in ClinicalTrials.gov with Target PharmaSolutions, Inc. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02954094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Longitudinal Observational Study of the Natural History and Management of Patients With Hepatocellular Carcinoma
Lead sponsor
Target PharmaSolutions, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
December 31, 2016
Completion date
February 28, 2027
Enrollment
10,000 (estimated)
Sites
71

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular cancer